Brokerages Set Chimera Investment Co. (CIM) Target Price at $18.50

Shares of Chimera Investment Co. (NYSE:CIM) have been assigned an average rating of “Hold” from the eight brokerages that are presently covering the company, MarketBeat reports. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and four have issued a buy rating on the company. The average 12-month price objective among analysts that have updated their coverage on the stock in the last year is $18.50.

A number of brokerages have commented on CIM. ValuEngine downgraded Chimera Investment from a “strong-buy” rating to a “buy” rating in a research note on Friday, February 2nd. Deutsche Bank upgraded Chimera Investment from a “hold” rating to a “buy” rating in a research note on Wednesday, January 31st. Credit Suisse Group upgraded Chimera Investment from a “neutral” rating to an “outperform” rating and lifted their target price for the company from $18.01 to $19.00 in a research note on Thursday, January 25th. Finally, Zacks Investment Research downgraded Chimera Investment from a “hold” rating to a “sell” rating in a research note on Tuesday, January 2nd.

Shares of Chimera Investment (NYSE CIM) traded down $0.02 during mid-day trading on Friday, reaching $16.77. The company’s stock had a trading volume of 77,859 shares, compared to its average volume of 1,431,728. The company has a debt-to-equity ratio of 2.72, a quick ratio of 0.02 and a current ratio of 0.02. Chimera Investment has a 12 month low of $15.77 and a 12 month high of $20.90. The firm has a market capitalization of $3,102.14, a P/E ratio of 5.15 and a beta of 0.60.

In other Chimera Investment news, CIO Mohit Marria acquired 3,000 shares of Chimera Investment stock in a transaction dated Friday, December 29th. The stock was acquired at an average cost of $25.82 per share, for a total transaction of $77,460.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.65% of the company’s stock.

Hedge funds and other institutional investors have recently modified their holdings of the company. The Manufacturers Life Insurance Company boosted its position in shares of Chimera Investment by 5.5% during the second quarter. The Manufacturers Life Insurance Company now owns 6,580 shares of the real estate investment trust’s stock worth $123,000 after buying an additional 341 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank boosted its position in shares of Chimera Investment by 77.2% during the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 7,545 shares of the real estate investment trust’s stock worth $139,000 after buying an additional 3,286 shares during the period. SG Americas Securities LLC acquired a new position in shares of Chimera Investment during the third quarter worth approximately $145,000. Fuller & Thaler Asset Management Inc. acquired a new position in shares of Chimera Investment during the fourth quarter worth approximately $170,000. Finally, Kovack Advisors Inc. acquired a new position in shares of Chimera Investment during the fourth quarter worth approximately $191,000. Institutional investors and hedge funds own 50.50% of the company’s stock.

COPYRIGHT VIOLATION WARNING: “Brokerages Set Chimera Investment Co. (CIM) Target Price at $18.50” was originally reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this article on another website, it was illegally stolen and republished in violation of U.S. and international copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2018/02/13/brokerages-set-chimera-investment-co-cim-target-price-at-18-50.html.

Chimera Investment Company Profile

Chimera Investment Corporation is a real estate investment trust (REIT). The company is engaged in the business of investing in a portfolio of mortgage assets, including agency residential mortgage-backed security (RMBS), non-agency RMBS, agency commercial mortgage-backed securities (CMBS), residential mortgage loans and real estate related securities.

Analyst Recommendations for Chimera Investment (NYSE:CIM)

Receive News & Ratings for Chimera Investment Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chimera Investment and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply